Benenden Health names chief commercial officer

Andy McClure takes the role

Jaskeet Briah
clock • 2 min read

Healthcare provider, Benenden Health, has appointed Andy McClure as its chief commercial officer (CCO), taking responsibility for the commercial strategy to support the health and wellbeing of members.

McClure has previously worked at AXA Health as marketing and propositions director, as well as managing director for Marsh UK&I and chief marketing officer for Europe at AIG. He was also part of the member advisory board for the International Federation of Health Plans. Tom Woolgrove, CEO, Benenden Health, said: "Benenden Health's commercial team is responsible for crucial services, from product and service development to B2B sales and timely and impactful marketing that inspires current and prospective members to engage with their health." As COO, McClure will work to drive Benenden ...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Insurer

Partner Insight: The Performance Gap

Partner Insight: The Performance Gap

Why operating model adaptability determines competitive outcomes in insurance

Sapiens
clock 21 May 2026 • 3 min read
Allianz makes four senior appointments to health business

Allianz makes four senior appointments to health business

Employee benefits, IPMI roles

Cameron Roberts
clock 18 May 2026 • 1 min read
61% of UK adults worried about being diagnosed with cancer: Vitality

61% of UK adults worried about being diagnosed with cancer: Vitality

Evolving protection needs

Cameron Roberts
clock 18 May 2026 • 1 min read